JK
Genus Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Continuous Genetic Gain | Livestock Productivity (Feed Efficiency, Yield) | Commercial |
| Disease Resistance (e.g., PRRS) | Porcine Disease | R&D |
| Sexed Semen Technology | Bovine Breeding Efficiency | Commercial |
| Advanced Reproductive Tech (IVF/ET) | Livestock Genetic Acceleration | Commercial/R&D |
| Sustainability Traits (Methane Reduction) | Bovine Emissions | Early R&D |
Leadership Team at Genus
IF
Iain Ferguson
Non-Executive Chairman
AR
Andy Russell
Chief Financial Officer
LG
Lysanne Gray
Non-Executive Director
LK
Lesley Knox
Senior Independent Director
DR
Dr. Ralph Heuser
Non-Executive Director
DC
Dr. Celia Baxter
Non-Executive Director
DB
Dr. Bob Reiter
Non-Executive Director
LG
Lucie Grant
Group General Counsel and Company Secretary